Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison, Madison, WI.
Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI.
PLoS One. 2020 Feb 6;15(2):e0228436. doi: 10.1371/journal.pone.0228436. eCollection 2020.
Cytochrome P450 1b1 (Cyp1b1) deletion and dietary retinol deficiency during pregnancy (GVAD) affect perinatal liver functions regulated by Srebp. Cyp1b1 is not expressed in perinatal liver but appears in the E9.5 embryo, close to sites of retinoic acid (RA) signaling.
Parallel effects of Cyp1b1 and retinol on postnatal Srebp derive from effects in the developing liver or systemic signaling.
Cluster postnatal increases in hepatic genes in relation to effects of GVAD or Cyp1b1 deletion. Sort expression changes in relation to genes regulated by Srebp1 and Srebp2.Test these treatments on embryos at E9.5, examining changes at the site of liver initiation. Use in situ hybridization to resolve effects on mRNA distributions of Aldh1a2 and Cyp26a1 (RA homeostasis); Hoxb1 and Pax6 (RA targets). Assess mice lacking Lrat and Rbp4 (DKO mice) that severely limits retinol supply to embryos.
At birth, GVAD and Cyp1b1 deletion stimulate gene markers of hepatic stellate cell (HSC) activation but also suppress Hamp. These treatments then selectively prevent the postnatal onset of genes that synthesize cholesterol (Hmgcr, Sqle) and fatty acids (Fasn, Scd1), but also direct cholesterol transport (Ldlr, Pcsk9, Stard4) and retinoid synthesis (Aldh1a1, Rdh11). Extensive support by Cyp1b1 is implicated, but with distinct GVAD interventions for Srebp1 and Srebp2. At E9.5, Cyp1b1 is expressed in the septum transversum mesenchyme (STM) with β-carotene oxygenase (Bco1) that generates retinaldehyde. STM provides progenitors for the HSC and supports liver expansion. GVAD and Cyp1b1-/- do not affect RA-dependent Hoxb1 and Pax6. In DKO embryos, RA-dependent Cyp26a1 is lost but Hoxb1 is sustained with Cyp1b1 at multiple sites.
Cyp1b1-/- suppresses genes supported by Srebp. GVAD effects distinguish Srebp1 and Srebp2 mediation. Srebp regulation overlaps appreciably in cholesterol and retinoid homeostasis. Bco1/Cyp1b1 partnership in the STM may contribute to this later liver regulation.
细胞色素 P450 1b1(Cyp1b1)缺失和妊娠期间的视黄醇缺乏(GVAD)会影响 Srebp 调节的围产期肝功能。Cyp1b1 在围产期肝脏中不表达,但在 E9.5 胚胎中出现,靠近维甲酸(RA)信号的部位。
Cyp1b1 和视黄醇对产后 Srebp 的平行影响源于发育中肝脏或全身信号的影响。
将与 GVAD 或 Cyp1b1 缺失相关的肝基因的产后增加进行聚类。根据 Srebp1 和 Srebp2 调节的基因对表达变化进行排序。在 E9.5 时用这些处理方法处理胚胎,检查在肝脏起始部位的变化。使用原位杂交解决 Aldh1a2 和 Cyp26a1(RA 稳态)mRNA 分布对 RA 信号的影响;Hoxb1 和 Pax6(RA 靶标)。评估严重限制胚胎视黄醇供应的缺乏 Lrat 和 Rbp4(DKO 小鼠)的小鼠。
出生时,GVAD 和 Cyp1b1 缺失刺激肝星状细胞(HSC)激活的基因标记,但也抑制 Hamp。这些处理随后选择性地阻止了合成胆固醇(Hmgcr、Sqle)和脂肪酸(Fasn、Scd1)的基因的产后起始,但也直接阻止了胆固醇转运(Ldlr、Pcsk9、Stard4)和视黄醇合成(Aldh1a1、Rdh11)。这暗示了 Cyp1b1 的广泛支持,但 GVAD 对 Srebp1 和 Srebp2 的干预是不同的。在 E9.5 时,Cyp1b1 在隔横突间质(STM)中表达,β-胡萝卜素加氧酶(Bco1)产生视黄醛。STM 为 HSC 提供祖细胞,并支持肝脏扩张。GVAD 和 Cyp1b1-/-不影响 RA 依赖性 Hoxb1 和 Pax6。在 DKO 胚胎中,RA 依赖性 Cyp26a1 丢失,但 Cyp1b1 在多个部位维持 Hoxb1。
Cyp1b1-/-抑制了 Srebp 支持的基因。GVAD 作用区分了 Srebp1 和 Srebp2 的介导。Srebp 调节在胆固醇和视黄醇稳态中重叠明显。STM 中的 Bco1/Cyp1b1 伙伴关系可能有助于这种后期的肝脏调节。